Skip to Content

Tag: Albuterol


Also Noted

ASP: Budesonide takes a dive

April 6, 2016HME News Staff

BALTIMORE - Second quarter payments for respiratory drugs are up in most cases, with the exception of Budesonide (J7626), which decreased sharply, down nearly 73 cents per dose. Perforomist (J7606) saw the biggest increase, up 41 cents to $9.82 per dose, according to the latest average sales price (ASP) figures. Brovana (J7605) increased 24 cents to $8.50 per dose. Albuterol (J7613) and ipratropium (J7644) stayed fairly flat, at 12.5 cents per dose and 10.5 cents per dose, respectively.

Albuterol, Average Sales Price, respiratory drugs


Specialty Providers

ASP: Budesonide reverses course

December 11, 2013HME News Staff

BALTIMORE - When it comes to nebulizer medication pricing, one quarter you're up; another quarter you're down.Average sales price (ASP) figures for the first quarter of 2014 revealed a decrease for budesonide (J7626) of nearly 35 cents to $5.60 per dose. That's in contrast to the previous quarter, when the drug increased 85 cents.The only other drugs to see increases for the upcoming quarter: brand names Brovana (J7605) and Perforomist (J7606), which increased 22 cents and 6 cents, respectively....

Albuterol, Average Sales Price, Brovana, Budesonide, Ipratropium, Neb meds, Perforomist


Read Full Articlered right arrow icon

Also Noted

ASP: Budesonide gets big boost

September 10, 2013HME News Staff

BALTIMORE - Things are looking up for several respiratory medications in the latest average sales price (ASP) figures. For the fourth quarter 2013, budesonide (J7626) took the biggest leap, up 85 cents to $5.95 per dose. Also getting an increase: brand name drugs Brovana (J7605) and Perforomist (J7606), which saw increases of 12 cents and nearly 39 cents per dose. Pricing stayed relatively flat for albuterol (J7613) and ipratropium (J7644) were both hovering around 12 cents per dose.

Albuterol, ASP Figures, Budesonide, neb-meds


Read Full Articlered right arrow icon

Specialty Providers

ASP: Budesonide back down

April 26, 2013Theresa Flaherty, Managing Editor

BALTIMORE - Pricing for budesonide took a plunge in the latest average sales price (ASP) figures for respiratory medications released in March.Budesonide (J7626) decreased 49 cents to $4.76 per dose for second quarter 2013. In the previous quarter, the drug saw an increase of 38 cents, to $5.26 per dose. Although a third generic version of budesonide has recently hit the market, it has had very limited distribution in the DME space and shouldn't have had much of an impact on pricing, says Wayne Vega,...

Albuterol, ASP, Neb meds


Read Full Articlered right arrow icon

Specialty Providers

Prices, audits stay the course

April 23, 2012Theresa Flaherty, Managing Editor

BALTIMORE - Brand-name Brovana took a hit in the latest average sales price (ASP) figures for nebulizer medications, but otherwise there were few major changes.The long-acting beta agonist Brovana (J7605) decreased 24 cents to $5.11 per dose in the latest figures, released in March.Between the lower reimbursement and a price increase from the manufacturer, you won't see many providers supplying the drug, said Sam Jarczynski, who blames market consolidation for the change.“There are so few respiratory...

Albuterol, Average Sales Prices, Brovana, Budesonide, neb-meds, Perforomist


Read Full Articlered right arrow icon

Specialty Providers

Providers threaten neb-med changes

October 28, 2010Theresa Flaherty, Managing Editor

BALTIMORE - As of Oct. 1, provider Sam Jarczynski no longer planned to dispense budesonide. That's because the latest average sales price figures, released on Sept. 20, showed a drop for the nebulizer medication of 56 cents, from $4.85 to $4.29. That's on top of the previous drop: $1.57. "We were breaking even on it, but now it's substantially lower than what our cost is on the drug," said Jarczynski, president of St. Petersburg, Fla.-based RxStat. "There's no way it can be dispensed to the Medicare...

Albuterol, Average Sales Prices, Neb meds, Pulmicort, respiratory meds


Read Full Articlered right arrow icon